US Stock MarketDetailed Quotes

GoodRx (GDRX)

Watchlist
  • 2.270
  • -0.080-3.40%
Close Apr 17 16:00 ET
  • 2.270
  • 0.0000.00%
Post 20:01 ET
777.64MMarket Cap25.22P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

GoodRx (GDRX) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
0.57%796.85M
-1.91%194.79M
0.40%196.03M
1.23%203.07M
2.57%202.97M
5.61%792.32M
0.99%198.58M
8.50%195.25M
5.76%200.61M
7.55%197.88M
Operating revenue
1.02%779.17M
-1.62%190.62M
0.81%191.39M
1.69%198.51M
3.16%198.59M
5.63%771.32M
1.22%193.75M
8.76%189.86M
5.66%195.21M
7.25%192.51M
Cost of revenue
19.46%57.6M
43.23%17.46M
14.85%13.42M
12.47%13.35M
7.19%13.36M
-27.96%48.22M
-19.62%12.19M
-37.59%11.68M
-27.35%11.87M
-25.32%12.47M
Gross profit
-0.65%739.26M
-4.87%177.32M
-0.52%182.61M
0.52%189.72M
2.26%189.61M
8.89%744.11M
2.71%186.39M
13.85%183.57M
8.89%188.74M
10.83%185.41M
Operating expense
-3.91%651.76M
-8.07%154.64M
2.96%167.99M
-3.52%162.91M
-6.63%166.23M
-4.52%678.26M
-15.79%168.21M
-18.24%163.16M
8.92%168.86M
14.13%178.03M
Selling and administrative expenses
-8.14%445.52M
-12.63%102.55M
0.05%115.55M
-6.44%113.25M
-12.89%114.17M
3.88%484.98M
-5.44%117.38M
-9.02%115.49M
12.44%121.04M
21.20%131.07M
-Selling and marketing expense
-9.68%331.56M
-16.21%78.62M
-7.05%83.53M
-9.19%84.87M
-6.03%84.54M
7.55%367.11M
0.08%93.83M
-1.91%89.87M
20.68%93.45M
14.57%89.96M
-General and administrative expense
-3.31%113.96M
1.66%23.94M
24.96%32.01M
2.86%28.38M
-27.92%29.63M
-6.10%117.86M
-22.47%23.55M
-27.46%25.62M
-8.67%27.59M
38.79%41.11M
Research and development costs
-2.20%121.03M
-8.82%28.94M
2.90%31.01M
-2.99%29.93M
0.40%31.14M
-8.90%123.75M
-0.91%31.74M
-23.91%30.14M
-1.38%30.85M
-5.75%31.02M
Depreciation amortization depletion
22.55%85.22M
21.21%23.15M
22.22%21.43M
16.29%19.73M
31.18%20.91M
-35.41%69.54M
-56.21%19.1M
-46.90%17.54M
5.39%16.97M
6.71%15.94M
-Depreciation and amortization
22.55%85.22M
21.21%23.15M
22.22%21.43M
16.29%19.73M
31.18%20.91M
-35.41%69.54M
-56.21%19.1M
-46.90%17.54M
5.39%16.97M
6.71%15.94M
Operating profit
32.87%87.49M
24.77%22.68M
-28.36%14.62M
34.87%26.81M
216.76%23.38M
343.81%65.85M
199.41%18.18M
153.24%20.41M
8.58%19.88M
-34.70%7.38M
Net non-operating interest income expense
-6.82%-31.67M
-25.74%-8.51M
-12.73%-8.52M
3.72%-7.93M
5.30%-6.71M
-20.74%-29.65M
-6.68%-6.77M
-24.49%-7.56M
-31.92%-8.23M
-20.16%-7.09M
Non-operating interest income
-53.02%10.93M
-58.82%1.89M
-51.87%2.31M
-55.75%2.8M
-47.95%3.93M
-27.66%23.27M
-45.87%4.59M
-44.54%4.8M
-18.94%6.33M
4.44%7.56M
Non-operating interest expense
-19.49%42.61M
-8.41%10.4M
-12.35%10.83M
-26.34%10.73M
-27.31%10.64M
-6.71%52.92M
-23.37%11.36M
-16.07%12.36M
3.64%14.57M
11.50%14.64M
Other net income (expense)
115.16%718K
24K
694K
-18.19%-4.74M
0
-115.32%-4.74M
Special income (charges)
--0
--0
--0
----
----
---2.08M
--0
---2.08M
----
----
-Less:Other special charges
----
----
----
----
----
--2.08M
--0
--2.08M
----
----
Other non- operating income (expenses)
126.99%718K
--24K
----
--694K
----
33.63%-2.66M
--0
-20.91%-2.66M
----
----
Income before tax
79.71%56.54M
24.40%14.19M
-24.80%6.1M
68.10%19.58M
5,588.74%16.67M
156.61%31.46M
146.31%11.41M
117.41%8.11M
-3.50%11.65M
-91.85%293K
Income tax
73.19%26.1M
87.79%8.77M
20.11%4.98M
35.99%6.73M
331.34%5.62M
132.27%15.07M
278.36%4.67M
151.16%4.15M
110.60%4.95M
-81.09%1.3M
Net income
85.72%30.44M
-19.51%5.43M
-71.78%1.12M
91.86%12.84M
1,195.34%11.05M
284.82%16.39M
126.05%6.74M
110.30%3.97M
-88.61%6.69M
69.33%-1.01M
Net income continuous Operations
85.72%30.44M
-19.51%5.43M
-71.78%1.12M
91.86%12.84M
1,195.34%11.05M
284.82%16.39M
126.05%6.74M
110.30%3.97M
-88.61%6.69M
69.33%-1.01M
Minority interest income
Net income attributable to the parent company
85.72%30.44M
-19.51%5.43M
-71.78%1.12M
91.86%12.84M
1,195.34%11.05M
284.82%16.39M
126.05%6.74M
110.30%3.97M
-88.61%6.69M
69.33%-1.01M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
85.72%30.44M
-19.51%5.43M
-71.78%1.12M
91.86%12.84M
1,195.34%11.05M
284.82%16.39M
126.05%6.74M
110.30%3.97M
-88.61%6.69M
69.33%-1.01M
Basic earnings per share
125.00%0.09
0.00%0.02
0
100.00%0.04
0.03
300.00%0.04
133.33%0.02
111.11%0.01
-85.71%0.02
0
Diluted earnings per share
125.00%0.09
0.00%0.02
0
100.00%0.04
0.03
300.00%0.04
133.33%0.02
111.11%0.01
-85.71%0.02
0
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 0.57%796.85M-1.91%194.79M0.40%196.03M1.23%203.07M2.57%202.97M5.61%792.32M0.99%198.58M8.50%195.25M5.76%200.61M7.55%197.88M
Operating revenue 1.02%779.17M-1.62%190.62M0.81%191.39M1.69%198.51M3.16%198.59M5.63%771.32M1.22%193.75M8.76%189.86M5.66%195.21M7.25%192.51M
Cost of revenue 19.46%57.6M43.23%17.46M14.85%13.42M12.47%13.35M7.19%13.36M-27.96%48.22M-19.62%12.19M-37.59%11.68M-27.35%11.87M-25.32%12.47M
Gross profit -0.65%739.26M-4.87%177.32M-0.52%182.61M0.52%189.72M2.26%189.61M8.89%744.11M2.71%186.39M13.85%183.57M8.89%188.74M10.83%185.41M
Operating expense -3.91%651.76M-8.07%154.64M2.96%167.99M-3.52%162.91M-6.63%166.23M-4.52%678.26M-15.79%168.21M-18.24%163.16M8.92%168.86M14.13%178.03M
Selling and administrative expenses -8.14%445.52M-12.63%102.55M0.05%115.55M-6.44%113.25M-12.89%114.17M3.88%484.98M-5.44%117.38M-9.02%115.49M12.44%121.04M21.20%131.07M
-Selling and marketing expense -9.68%331.56M-16.21%78.62M-7.05%83.53M-9.19%84.87M-6.03%84.54M7.55%367.11M0.08%93.83M-1.91%89.87M20.68%93.45M14.57%89.96M
-General and administrative expense -3.31%113.96M1.66%23.94M24.96%32.01M2.86%28.38M-27.92%29.63M-6.10%117.86M-22.47%23.55M-27.46%25.62M-8.67%27.59M38.79%41.11M
Research and development costs -2.20%121.03M-8.82%28.94M2.90%31.01M-2.99%29.93M0.40%31.14M-8.90%123.75M-0.91%31.74M-23.91%30.14M-1.38%30.85M-5.75%31.02M
Depreciation amortization depletion 22.55%85.22M21.21%23.15M22.22%21.43M16.29%19.73M31.18%20.91M-35.41%69.54M-56.21%19.1M-46.90%17.54M5.39%16.97M6.71%15.94M
-Depreciation and amortization 22.55%85.22M21.21%23.15M22.22%21.43M16.29%19.73M31.18%20.91M-35.41%69.54M-56.21%19.1M-46.90%17.54M5.39%16.97M6.71%15.94M
Operating profit 32.87%87.49M24.77%22.68M-28.36%14.62M34.87%26.81M216.76%23.38M343.81%65.85M199.41%18.18M153.24%20.41M8.58%19.88M-34.70%7.38M
Net non-operating interest income expense -6.82%-31.67M-25.74%-8.51M-12.73%-8.52M3.72%-7.93M5.30%-6.71M-20.74%-29.65M-6.68%-6.77M-24.49%-7.56M-31.92%-8.23M-20.16%-7.09M
Non-operating interest income -53.02%10.93M-58.82%1.89M-51.87%2.31M-55.75%2.8M-47.95%3.93M-27.66%23.27M-45.87%4.59M-44.54%4.8M-18.94%6.33M4.44%7.56M
Non-operating interest expense -19.49%42.61M-8.41%10.4M-12.35%10.83M-26.34%10.73M-27.31%10.64M-6.71%52.92M-23.37%11.36M-16.07%12.36M3.64%14.57M11.50%14.64M
Other net income (expense) 115.16%718K24K694K-18.19%-4.74M0-115.32%-4.74M
Special income (charges) --0--0--0-----------2.08M--0---2.08M--------
-Less:Other special charges ----------------------2.08M--0--2.08M--------
Other non- operating income (expenses) 126.99%718K--24K------694K----33.63%-2.66M--0-20.91%-2.66M--------
Income before tax 79.71%56.54M24.40%14.19M-24.80%6.1M68.10%19.58M5,588.74%16.67M156.61%31.46M146.31%11.41M117.41%8.11M-3.50%11.65M-91.85%293K
Income tax 73.19%26.1M87.79%8.77M20.11%4.98M35.99%6.73M331.34%5.62M132.27%15.07M278.36%4.67M151.16%4.15M110.60%4.95M-81.09%1.3M
Net income 85.72%30.44M-19.51%5.43M-71.78%1.12M91.86%12.84M1,195.34%11.05M284.82%16.39M126.05%6.74M110.30%3.97M-88.61%6.69M69.33%-1.01M
Net income continuous Operations 85.72%30.44M-19.51%5.43M-71.78%1.12M91.86%12.84M1,195.34%11.05M284.82%16.39M126.05%6.74M110.30%3.97M-88.61%6.69M69.33%-1.01M
Minority interest income
Net income attributable to the parent company 85.72%30.44M-19.51%5.43M-71.78%1.12M91.86%12.84M1,195.34%11.05M284.82%16.39M126.05%6.74M110.30%3.97M-88.61%6.69M69.33%-1.01M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 85.72%30.44M-19.51%5.43M-71.78%1.12M91.86%12.84M1,195.34%11.05M284.82%16.39M126.05%6.74M110.30%3.97M-88.61%6.69M69.33%-1.01M
Basic earnings per share 125.00%0.090.00%0.020100.00%0.040.03300.00%0.04133.33%0.02111.11%0.01-85.71%0.020
Diluted earnings per share 125.00%0.090.00%0.020100.00%0.040.03300.00%0.04133.33%0.02111.11%0.01-85.71%0.020
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +14.09%
Sample Name
Sample Code
 +3.93%
Sample Name
Sample Code
 +2.06%
4
United States Oil Fund LP
USO
-1.12%
5
United States Gasoline Fund Lp
UGA
-2.10%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +22.28%
Sample Name
Sample Code
 +20.52%
Sample Name
Sample Code
 +19.71%
4
Zai Lab
ZLAB
+16.97%
5
Legend Biotech
LEGN
+16.57%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Lebanon and Israel will implement a 10-day ceasefire! Iran's foreign minister, based on the Lebanon ceasefire agreement, announced the compl Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -